New Combination Treatment Offers Hope for Chronic Lymphocytic Leukemia Patients
A recent study has revealed promising results for chronic lymphocytic leukemia (CLL) patients, suggesting that a combination treatment may allow some individuals to discontinue daily use of the medication ibrutinib.…